OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy
Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4095-4111
Open Access | Times Cited: 42
Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4095-4111
Open Access | Times Cited: 42
Showing 26-50 of 42 citing articles:
In Silico Identification of Dysregulated miRNAs Targeting KRAS Gene in Pancreatic Cancer
Asbiel Felipe Garibaldi-Ríos, Luis E. Figuera, Guillermo Moisés Zúñiga‐González, et al.
Diseases (2024) Vol. 12, Iss. 7, pp. 152-152
Open Access | Times Cited: 1
Asbiel Felipe Garibaldi-Ríos, Luis E. Figuera, Guillermo Moisés Zúñiga‐González, et al.
Diseases (2024) Vol. 12, Iss. 7, pp. 152-152
Open Access | Times Cited: 1
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer
Immacolata Maietta, Eleonora Viscusi, Stefano Laudati, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1546-1546
Open Access | Times Cited: 1
Immacolata Maietta, Eleonora Viscusi, Stefano Laudati, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1546-1546
Open Access | Times Cited: 1
KRAS, a New Target for Precision Medicine in Colorectal Cancer?
Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3455-3455
Open Access | Times Cited: 1
Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3455-3455
Open Access | Times Cited: 1
Overcoming Irinotecan Resistance by Targeting Its Downstream Signaling Pathways in Colon Cancer
Shashank Saurav, Sourajeet Karfa, Trung Vu, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3491-3491
Open Access | Times Cited: 1
Shashank Saurav, Sourajeet Karfa, Trung Vu, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3491-3491
Open Access | Times Cited: 1
PKN2 is a dependency of the mesenchymal-like cancer cell state
Shane T. Killarney, Gabriel Mesa, Rachel Washart, et al.
Cancer Discovery (2024) Vol. 15, Iss. 3, pp. 595-615
Closed Access | Times Cited: 1
Shane T. Killarney, Gabriel Mesa, Rachel Washart, et al.
Cancer Discovery (2024) Vol. 15, Iss. 3, pp. 595-615
Closed Access | Times Cited: 1
The Hippo pathway: organ size control and beyond
Pengfei Guo, Sicheng Wan, Kun‐Liang Guan
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100031-100031
Closed Access | Times Cited: 1
Pengfei Guo, Sicheng Wan, Kun‐Liang Guan
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100031-100031
Closed Access | Times Cited: 1
CRISPR technology in lung diseases: the example of lung cancer and cystic fibrosis
José M. Porcel, Mariona Pont, Anabel Sorolla
Archivos de Bronconeumología (2024) Vol. 60, Iss. 7, pp. 397-399
Closed Access
José M. Porcel, Mariona Pont, Anabel Sorolla
Archivos de Bronconeumología (2024) Vol. 60, Iss. 7, pp. 397-399
Closed Access
Reporter-based screening identifies RAS-RAF stabilizing mutations as drivers of resistance to broad-spectrum RAS inhibition in colorectal cancer
Oleksandra Aust, Eric Blanc, Mareen Lüthen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Oleksandra Aust, Eric Blanc, Mareen Lüthen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Fibroblasts Promote Resistance to KRAS Silencing in Colorectal Cancer Cells
Susana Mendonça, Patrícia Dias Carvalho, André Serra‐Roma, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2595-2595
Open Access
Susana Mendonça, Patrícia Dias Carvalho, André Serra‐Roma, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2595-2595
Open Access
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer
Muhammad Aamir Wahab, Nunzio Del Gaudio, Biagio Gargiulo, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3026-3026
Open Access
Muhammad Aamir Wahab, Nunzio Del Gaudio, Biagio Gargiulo, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3026-3026
Open Access
The Phenotypical Characterization of Dual-Nature Hybrid Cells in Uveal Melanoma
Emily Marcotte, Alicia A. Goyeneche, Mohamed Abdouh, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3231-3231
Open Access
Emily Marcotte, Alicia A. Goyeneche, Mohamed Abdouh, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3231-3231
Open Access
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling
Rachel Nakagawa, Andrew Beardsley, Sophia Durney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rachel Nakagawa, Andrew Beardsley, Sophia Durney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anticancer potential of isoalantolactone in testicular cancer: an analysis of cytotoxicity, apoptosis, and signaling pathways
Ming‐Tse Sung, Hsuan-En Huang, Ya-Chuan Chang, et al.
Aging (2024) Vol. 16, Iss. 19, pp. 12820-12832
Open Access
Ming‐Tse Sung, Hsuan-En Huang, Ya-Chuan Chang, et al.
Aging (2024) Vol. 16, Iss. 19, pp. 12820-12832
Open Access
Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3863-3863
Open Access
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3863-3863
Open Access
Targeting undruggable protein KRAS for cancer therapy: novel opportunities and challenges
Xin Yang, Xiang Li, Yuelin Zhang, et al.
Future Medicinal Chemistry (2024), pp. 1-5
Closed Access
Xin Yang, Xiang Li, Yuelin Zhang, et al.
Future Medicinal Chemistry (2024), pp. 1-5
Closed Access
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
Fiona Healy, Amy L. Turner, Vanessa Marensi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Fiona Healy, Amy L. Turner, Vanessa Marensi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
All Roads Lead to Rome: YAP/TAZ Activity Influences Efficacy of KRASG12C Inhibitors
Christian W. Johnson, Kevin M. Haigis
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4005-4007
Closed Access | Times Cited: 1
Christian W. Johnson, Kevin M. Haigis
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4005-4007
Closed Access | Times Cited: 1
